MYOSIN THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98919247
- Mark type
- Design + words
- Filed
- 23 Dec 2024
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Ehab Samuel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of glioblastoma; pharmaceutical products for the treatment of cancer, namely glioblastoma, brain cancer, and metastatic cancers; pharmaceutical preparations for the treatment of methamphetamine use disorder; pharmaceutical preparations for the treatment of cocaine use disorder; pharmaceutical preparations for the treatment of stimulant use disorder, namely methamphetamine use disorder and cocaine use disorder
- Class 042 — Scientific and technological services: Medical and scientific research in the field of cancer treatment; medical and scientific research in the field of stimulant use disorders
Owner
- Myosin Therapeutics, Inc., Jupiter, FL, US
- Myosin Therapeutics, Inc., Jupiter, FL, US
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Jun 2025 — NON-FINAL ACTION E-MAILED
- 13 Jun 2025 — NON-FINAL ACTION WRITTEN
- 09 Jun 2025 — ASSIGNED TO EXAMINER
- 29 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 29 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Dec 2024 — NEW APPLICATION ENTERED